Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System

Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The US FDA has approved several therapeutics and vaccines worldwide through the emergency use authorization in response to the rapid s...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yunjiao, Qu, Jing, Wei, Lan, Liao, Shumin, Zheng, Nianzhen, Liu, Yingzi, Wang, Xingyun, Jing, Yue, Shen, Clifton Kwang-Fu, Ji, Chong, Luo, Guxun, Zhang, Yiyun, Xiang, Qi, Fu, Yang, Li, Shuo, Fan, Yunping, Fang, Shisong, Wang, Peng, Li, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559598/
https://www.ncbi.nlm.nih.gov/pubmed/34733269
http://dx.doi.org/10.3389/fimmu.2021.689065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559598/
https://www.ncbi.nlm.nih.gov/pubmed/34733269
http://dx.doi.org/10.3389/fimmu.2021.689065

Ejemplares similares